Light gray square, with a dark gray border on the sides.

Blog

The Measurement Work Behind Every Structural Plan

October 10, 2026

Part 3 of 6 in Circle CVI's Structural Heart series. Every Scan. One Plan. One Platform.


Ask who plans a structural heart case and you will usually hear the name of a physician. Ask what the plan is made of and you arrive somewhere else: a centralized 3D lab, a queue of studies covering three different procedures, and an analyst doing the measurement work that everyone downstream treats as fact.



That work is the most standardized thing in the structural program and the least discussed.

Three procedures, three anatomies, three sets of rules


The structural caseload does not divide neatly. A 3D lab supporting a full program handles aortic, mitral and left atrial appendage work in the same week, and the three have almost nothing in common beyond the scanner.


Aortic planning turns on annulus area and perimeter, coronary heights, calcification distribution, and access. The SCCT expert consensus covers the full sequence, and the ESCR consensus adds a reporting template for it.


Mitral planning turns on something else entirely. The predicted neo-LVOT determines whether transcatheter mitral valve replacement is safe at all, and the thresholds are tight. A registry of 194 patients found a predicted neo-LVOT below 170 mm² was 96.2 percent sensitive and 92.3 percent specific for LVOT obstruction, and current practice broadly treats 170 to 200 mm² as the range below which TMVR is not safe without a modification strategy. That is a measurement where being 20 mm² out changes the answer to a yes-or-no question.


LAAC planning turns on appendage morphology, ostial dimensions, device landing zone, and transseptal puncture orientation. The 2025 SCAI/HRS clinical practice guideline suggests obtaining pre-procedural TEE or CT rather than omitting it, a conditional recommendation on very low certainty evidence. The EHRA/EAPCI consensus is more forthcoming about why CT gets used: superior spatial resolution, detailed three-dimensional characterization of appendage anatomy, accurate sizing, and non-invasive acquisition. Delayed-acquisition CT reaches 100 percent sensitivity and 98 to 100 percent specificity for appendage thrombus.


One analyst. Three anatomies. Often three applications.


Standardization is the product


The 3D lab exists because a centralized reader produces a more consistent measurement than a distributed one. The evidence agrees: in a study of repeated annulus measurement, moving from a single reader to a multi-reader strategy cut device-size disagreement from 22 to 26 percent down to 5 to 10 percent.


Centralization delivers that only if the method is genuinely the same each time. Which is where the tooling starts to matter more than it looks like it should. Comparing two established planning packages on the same 100 patients, mean annulus area differed significantly between them, 482 mm² against 464 mm², along with perimeter and both coronary heights. A lab running one package for aortic and another for mitral is not running one standard. It is running two, and the report does not say which.


There is also the question of how much correction the automation needs. In that same comparison, accepting the fully automated output without review would have changed prosthesis size in 18 percent of patients. Reviewing and correcting the contours brought it to 4 percent. The lab's value is concentrated precisely in that gap.


What the LAAC evidence actually shows


LAAC is the procedure where planning software has been tested most rigorously, and the results are worth knowing accurately rather than in the version that appears on a slide.


PREDICT-LAA randomized 200 patients to standard planning or CT simulation-based planning. Its primary composite endpoint was not met, at a relative risk of 0.69 with a confidence interval crossing one and a p-value of 0.08. That is the honest headline and it should be stated first. The secondary endpoints are where the operational case sits: procedure time fell from 55.2 to 45.1 minutes, fluoroscopy time from 17.6 to 12.5 minutes, contrast volume from 80 to 59 mL, and the proportion of cases requiring more than three device repositionings dropped from 22.7 percent to 10.0 percent.


A 2026 meta-analysis across six studies and 978 patients found procedure time shorter by 13.29 minutes with CCTA planning and device resizing reduced at a relative risk of 0.42, with implantation success modestly improved. Contrast and radiation dose showed no significant difference. A separate meta-analysis reached a less favorable conclusion on implantation success, and anyone citing this literature should acknowledge that the two disagree.


The cleanest single finding comes from a subanalysis nested inside a randomized trial. Among 219 LAAC procedures preceded by CT, operators unblinded to the CT achieved short-term procedural success in 93.5 percent of cases against 81.1 percent for blinded operators, an adjusted odds ratio of 2.76. The blinding was not itself randomized, so this is association rather than causation. It is still the most direct evidence available that the planning work changes what happens in the lab.


The measurement the analyst produces is not documentation. It is a variable in the procedure.


Fewer clicks is more cases


Post-processing time is the constraint the 3D lab lives inside, and it is a documented one. A systematic appraisal of 440 imaging studies found that 48.3 percent would increase radiologist workload against 4.5 percent that would reduce it, with increased post-processing time named among the dominant mechanisms.


Reducing that time is not about the analyst working faster. It is about removing the repetitive placement work that produces neither insight nor variance reduction. In cvi42, assisted annulus and landmark detection across the Interventional Planning Suite covering aortic, mitral and LAAC removes 80 to 100 clicks from a typical case, by Circle's own measurement. Semi-automated measurement in a comparable published setting cut reading time roughly in half, from 3.14 minutes to 1.50, while producing an identical area-derived prosthesis size in 96 percent of cases for an experienced reader.


The analyst still reviews and corrects every contour. That is the part that carries the value, and it is the part that survives when the clicking goes away.


One platform across the caseload


The argument for consolidating the 3D lab onto a single platform is not a preference for tidiness. It is that three applications produce three measurement standards, three training curves, three upgrade cycles, three output formats for the heart team to reconcile, and three sets of credentials.


cvi42 covers aortic, mitral and LAAC planning in one environment, alongside the cardiac CT and cardiac MR the same lab often supports. LAAC planning for WATCHMAN TruPlan was developed by Circle working directly with Boston Scientific, which is why the appendage workflow behaves like something designed around the device rather than adapted to it. Measurements populate a structured report and reach the reporting environment through PowerScribe One, DICOM SR or HL7.


One method, applied the same way to every case, with the physician review loop exactly where it was.


See the structural planning workflow in cvi42 →


Stay tuned for more on Structural Heart from the perspective of imaging lab directors and department heads, IT and PACS, and procurement and administration.


Person at a cardiac workstation reviewing screens with green-themed interface and data visuals
October 6, 2026
Part 2 of 6 in Circle CVI's Structural Heart series. Every Scan. One Plan. One Platform. A diagnostic cardiac CT report ends in an impression. A structural planning report ends in a set of numbers that a heart team will use to select a device. That is a different product. The impression tolerates hedging, because the clinician reading it brings their own judgment to the question. The planning report does not, because a millimeter of annulus perimeter is not an opinion to be weighed. It is an input to a sizing chart. Imaging physicians have absorbed this shift largely without anyone naming it.
Two people in lab coats discuss a heart scan on a monitor in a green-toned medical office.
September 29, 2026
Part 1 of 6 in Circle CVI's Structural Heart series. Every Scan. One Plan. One Platform. The annulus measurement decides the case. Valve choice follows from it. So does sizing, so does the degree of oversizing, so does whether the root tolerates that oversizing, and so does whether you spend the end of an otherwise clean case managing a paravalvular leak. By the time the patient is on the table, that measurement was made days earlier, in a post-processing application the operator may never open, by a reader whose work arrives as a number on a report.  For a procedure this dependent on millimeters, that is worth examining.
August 13, 2026
Part 5 of 5 in Circle's Coronary Plaque series. Also read: Part 1 — How Advanced Plaque Analysis Changes the Clinic al Calculus Part 2 — Th e IT Infrastructure Behind CCTA Plaque Analysis Part 3 — The Financial Case for Coronary Plaque Services Part 4 — D elivering Plaque Analysis Without Disrupting Your Department You have watched the trajectory. Twelve months ago, the conversation about coronary plaque analysis was happening at conferences. Six months ago, it was happening in your referring cardiologists' offices. Now it is happening in your reading room — which lesions are vulnerable, what the total plaque burden is, whether coronary plaque tells a different story than the stenosis grade. That part is good news. Your patients are getting better assessments and the evidence base is catching up to the clinical intuition. On January 1, 2026, the financial case caught up too: the AMA retired the Category III plaque codes (0623T–0626T) and replaced them with a single Category I code, CPT 75577 , for AI-enabled coronary plaque assessment ( ACC Coding Corner ). Plaque analysis is no longer an emerging-technology line item. It is a national fee-schedule procedure. The harder question is operational: is your program set up to deliver it on its own — or to send the studies out and watch most of the reimbursement leave with them? For programs already running CCTA at any meaningful scale, becoming your own plaque lab is more accessible than most assume. It is a workflow choice, not a capital project.
Four people in a modern office meeting around a desk with multiple computer monitors.
June 25, 2026
Part 4 of 5 in Circle's Coronary Plaque series. Also read: Part 1 — How Advanced Plaque Analysis Changes the Clinical Calculus Part 2 — The IT Infrastructure Behind CCTA Plaque Analysis Part 3 — The Financial Case for Coronary Plaque Services It's Monday morning review. Throughput is off target again. Two radiologists are working through a backlog of CCTA studies from Friday. Your most experienced cardiac CT tech just submitted a PTO request for a week in July that you can't cover without asking someone else to come in. And now cardiology has sent a note asking why the plaque analysis reports are taking so long. This scenario is not unique to your department. It is the operational reality facing most cardiac imaging programs as CCTA volume grows and clinical expectations evolve faster than workflows do. Coronary plaque analysis has moved from a research capability to a clinical standard — driven by updated ACC/AHA Chest Pain Guidelines , 10-year SCOT-HEART outcomes and the ongoing SCOT-HEART 2 trial , and a growing population of patients and referring physicians who know what to ask for. Meeting that expectation with a manual workflow built for a simpler era of CCTA reporting is not a sustainable operating model. The question is not whether to offer plaque analysis. The question is how to build the workflow to deliver it without adding to a backlog that's already under pressure.

Subscribe to our newsletter

 Don’t miss future articles or publications.